Please provide your email address to receive an email when new articles are posted on . SGLT2 inhibitor use may reduce the risk for Alzheimer’s disease, Parkinson’s disease and vascular dementia. The ...
Dr. Sam Gandy answers the question: 'Other Causes Of Dementia?' May 4, 2009 -- Question: Could dementia be caused by something other than Alzheimer's disease? Answer: Alzheimer's disease is the most ...
A specific type of diabetes medication has been associated with a lower risk of dementia, Alzheimer's and Parkinson's disease in a study published today. The South Korean study followed 358,862 ...
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows. Sodium-glucose cotransporter-2 (SGLT2) inhibitors, also known as gliflozins, ...
The study looked at sodium-glucose cotransporter-2 (SGLT2) inhibitors, which are also known as gliflozins. They lower blood sugar by causing the kidneys to remove sugar from the body through urine.
The rate of neurodegenerative conditions is growing globally, meaning that a lot of research is into prevention of these problems. There has been some research suggesting that a type of type 2 ...
A class of drugs used to treat diabetes has been linked to a 20% lower risk of dementia and Parkinson’s disease. The corresponding study was published in Neurology. “We know that these ...
Men treated with androgen deprivation therapy (ADT) for prostate cancer had a significantly higher risk of dementia and other neurocognitive disorders, according to a meta-analysis of more than 2.5 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback